Mezzion Pharma CEO Park Donghyun Increases Stake Through Open Market Purchases, Maintains 6.09% Ownership

Mezzion Pharma's CEO and de facto controlling shareholder Donghyun Park acquired an additional 1,022 common shares through open market purchases on July 14, 2026.
The average acquisition price was 48,749 KRW per share, below the current market price of 54,800 KRW as of the report date.
Park's total holdings increased to 1,850,983 shares, but the ownership ratio remained unchanged at 6.09% of total outstanding shares.
This report reflects only a minor open market purchase; no capital changes, dividends, or share buybacks were disclosed.
[AI Summary]The CEO's small insider purchase demonstrates management confidence but has limited direct impact on the stock price. Given the absence of additional capital policy changes or dividend adjustments, the short-term outlook remains neutral.